July 2014 Blog Posts (9)

Study Shows Acupuncture Helps Reduce Fatigue, Anxiety and Depression in Patients Using Aromatase Inhibitors to Prevent Recurrence of Breast Cancer

Electro-acupuncture (EA), a form of acupuncture where a small electric current is passed between pairs of acupuncture needles, produces significant improvements in fatigue, anxiety and depression in as little as eight weeks for early stage breast cancer patients experiencing joint pain related to the use of aromatase inhibitors (AIs) to treat breast cancer.

This conclusion is based on a randomized, placebo-controlled trial examining the intervention led by researchers at…

Continue

Added by Editorial Team on July 30, 2014 at 10:00am — No Comments

Some Bladder Cancer Patients may Benefit from Hypoxia Modification - Making Radiotherapy more Effective

Scientists from the The University of Manchester in Manchester, United Kingdom, have identified a protein that could help doctors decide which bladder cancer patients would benefit from a treatment that makes radiotherapy more effective, according to a study [1] published in the British Journal of Cancer (BJC) on Wednesday.

The team from The University of Manchester, funded by the Medical Research Council,…

Continue

Added by Editorial Team on July 30, 2014 at 9:30am — No Comments

Breast Cancer Treatment Response to Tamoxifen Predicted by Gene Signature

Tamoxifen (Soltamox/Nolvadex®; AstraZeneca), an antagonist of the estrogen receptor α in ERα-positive breast cancer has been effective in most patients. The drug has been used for more than 40 years to treat breast cancers that are hormone-receptor positive. As an adjuvant therapy tamoxifen improves overall survival. Its widespread use is thought to have made a significant contribution to the…

Continue

Added by Editorial Team on July 17, 2014 at 5:00pm — No Comments

Lack of Teenage Participants in Clinical Trials Concerns Researchers

A report from the National Cancer Research Institute (NCRI), published in the Lancet Oncology, says that age limits on clinical trials need to be more flexible to allow more teenage cancer patients the chance to access new treatments options. Under-representation of teenagers and young adults in clinical trials for cancer has been confirmed to be one of the primary reasons of the lower survival gains in this group of patients. The study, funded by the National Institute for Health…

Continue

Added by Editorial Team on July 7, 2014 at 1:30pm — No Comments

Two Cancer Mutations may be Targets for Effective Melanoma Immunotherapy

Results of a study published in the July 1, 2014 issue of Clinical Cancer Research, a journal of the American Association for Cancer Research (AACR), suggest that the recognition of unique cancer mutations appeared to be responsible for complete cancer regressions in two metastatic melanoma patients treated with a type of immunotherapy called adoptive T-cell therapy. This new approach may help develop more effective cancer immunotherapies.

"This study provides the technical…

Continue

Added by Editorial Team on July 1, 2014 at 8:30pm — No Comments

Inhibition of Galectin-1 may Offer Urgently Needed Treatment Option for Pancreatic Cancer

According to data from the American Cancer Society, pancreatic cancer, common in most developed countries, accounts for about 3% of all cancers in the United States - and about 7% of all cancer deaths.  The survival rates are less than 2%, 5 years after diagnosis. The same data shows that the average lifetime risk of developing pancreatic cancer is about 1 in 67 (1.5%). Pancreatic adenocarcinoma is among the most aggressive of all cancers. Because the majority (53%) of all patients newly…

Continue

Added by Editorial Team on July 1, 2014 at 4:30pm — No Comments

Do Patients Benefit from Increase Breast Cancer Screening?

According to a study, supported by the National Cancer Institute and the P30 Cancer Center Support Grant (CCSG), published by Yale School of Medicine researchers in the July 1, 2014 issue of the Journal of the National Cancer Institute, breast cancer screening costs for Medicare patients skyrocketed between 2001 and 2009. However, they conclude, this increase did not lead to earlier detection of new breast cancer cases.

While the number of screening mammograms performed among…

Continue

Added by Editorial Team on July 1, 2014 at 3:00pm — No Comments

Extract of the Thunder God Vine may be Effective in Blocking a Protein that helps Pancreatic Cancer Cells Survive, Study Shows

A postive diagnosis of pancreatic cancer can be devastating. According to the Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute, the number of new cases of pancreas cancer is expected to result in 12.3 per 100,000 men and women in 2014. The number of deaths is expected to reach 10.9 per 100,000 men and women per year. The lifetime Risk of Developing Cancer is approximately 1.5% of men and women will be diagnosed with pancreas cancer at some point…

Continue

Added by Editorial Team on July 1, 2014 at 1:30pm — No Comments

Aspirin Slows Age-related Decay of Gene Markers

Cancer risk increases with age. In addition, lifestyle factors also impact the development of cancer. Study results published in the Journal of the National Cancer Institute shows that researchers from the University of Basel have shown that aspirin use and smoking both influence aging processes of the female genome connected to colorectal cancer.

As early as the 1990s, scientists discovered that regular use of aspirin over long periods of time decreases the cancer risk.…

Continue

Added by Editorial Team on July 1, 2014 at 10:30am — No Comments

Monthly Archives

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2005

2004

2001

Register for free to view all the Onco'Zine - The International Oncology Network content:

ADVERTISEMENT/MEDIA PARTNER

Onco'Zine is present here

Bookmark / Share

CONNECT WITH US AND

JOIN THE CONVERSATION


© 2017   Created by Peter Hofland, PhD.   Powered by

Badges  |  Report an Issue  |  Terms of Service

Find us on Google+